EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report) shares traded up 28.5% on Wednesday . The stock traded as high as $0.13 and last traded at $0.13. 41,000 shares were traded during trading, an increase of 271% from the average session volume of 11,050 shares. The stock had previously closed at $0.10.
EV Biologics Trading Down 18.6 %
The business’s fifty day moving average is $0.15 and its 200-day moving average is $0.22.
About EV Biologics
EV Biologics, Inc, a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces.
See Also
- Five stocks we like better than EV Biologics
- What is Short Interest? How to Use It
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Investing In Preferred Stock vs. Common Stock
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for EV Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EV Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
